The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ODM-204 a novel dual inhibitor of CYP17A1 and androgen receptor: Early results from phase I dose escalation in men with castration-resistant prostate cancer.
 
Karim Fizazi
Honoraria - Astellas Pharma; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Curevac; ESSA; Janssen Oncology; Orion; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Amgen
 
Robert Hugh Jones
No Relationships to Disclose
 
Christophe Massard
No Relationships to Disclose
 
Egils Vjaters
Travel, Accommodations, Expenses - Ipsen
 
Katriina Johanna Peltola
Employment - Orion
Stock and Other Ownership Interests - Faron Pharmaceuticals
Honoraria - Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; MSD; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Pirjo Nykänen
Employment - Orion
 
Annamari Vuorela
Employment - Orion
 
Riikka Oksala
Employment - Orion
 
Pasi Pohjanjousi
Employment - Orion
 
Mika VJ Mustonen
Employment - Orion
 
Petri Bono
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Orion; Pfizer
Research Funding - Novartis